Testing effectiveness (Phase 2)UnknownNCT05124028What this trial is testingOrelabrutinib in Patients With ITPWho this might be right forImmune Thrombocytopenia Peking University People's Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT01129024What this trial is testingAn Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Shionogi 19
Early research (Phase 1)Study completedNCT02281370What this trial is testingDrug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy SubjectsWho this might be right forPurpura, Thrombocytopenic, Idiopathic GlaxoSmithKline 39
Post-approval studies (Phase 4)WithdrawnNCT02642380What this trial is testingDifferent Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Shandong University
Post-approval studies (Phase 4)Study completedNCT01356511What this trial is testingHigh-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)Who this might be right forPurpura, Thrombocytopenic, Idiopathic Shandong University 261
Testing effectiveness (Phase 2)Looking for participantsNCT07063199What this trial is testingAnti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)Who this might be right forImmune ThrombocytopeniaTreatment Institute of Hematology & Blood Diseases Hospital, China 30
Large-scale testing (Phase 3)Study completedNCT00370331What this trial is testingRAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With EltrombopagWho this might be right forPurpura, Thrombocytopaenic, Idiopathic GlaxoSmithKline 197
Large-scale testing (Phase 3)UnknownNCT02270801What this trial is testingRecombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in PregnancyWho this might be right forImmune ThrombocytopeniaPregnancy Shandong University 30
Large-scale testing (Phase 3)Study completedNCT04516967What this trial is testingAvatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 MonthsWho this might be right forImmune Thrombocytopenia Sobi, Inc. 75
Very early researchLooking for participantsNCT06519565What this trial is testingSafety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 6
Not applicableEnrolling By InvitationNCT02422875What this trial is testingComparative Autoantibody and Immunologic Cell Marker StudyWho this might be right forAutoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases Emory University 2,500
Testing effectiveness (Phase 2)Ended earlyNCT00225875What this trial is testingStudy of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a SplenectomyWho this might be right forAutoimmune Thrombocytopenic Purpura Assistance Publique - Hôpitaux de Paris 65
Not applicableUnknownNCT02892630What this trial is testingImmune Thrombocytopenia in PregnancyWho this might be right forImmune ThrombocytopeniaPregnancy Assistance Publique - Hôpitaux de Paris 300
Not applicableUnknownNCT05333861What this trial is testingAn Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AAWho this might be right forPrimary Immune ThrombocytopeniaAplastic Anemia Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,150
Not applicableLooking for participantsNCT06107582What this trial is testingLongitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)Who this might be right forPrimary Immune Thrombocytopenia Institute of Hematology & Blood Diseases Hospital, China 500
Testing effectiveness (Phase 2)UnknownNCT06176911What this trial is testingThe Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Peking University People's Hospital 124
Not applicableNot Yet RecruitingNCT07070193What this trial is testingLongitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic StrokeWho this might be right forImmune Thrombocytopenia (ITP)Acute Ischemic Stroke Peking University People's Hospital 500
Very early researchUnknownNCT06417398What this trial is testingPreliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT01652599What this trial is testingEltrombopag and High-dose Dexamethasone as First Line Treatment for ITWho this might be right forImmune Thrombocytopenic Purpura Hospital Universitario Dr. Jose E. Gonzalez 30
Testing effectiveness (Phase 2)Study completedNCT00372892What this trial is testingPilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)Who this might be right forPurpura, Thrombocytopenic, Idiopathic Hamilton Health Sciences Corporation 60